FDA Approves Nipocalimab for Adult and Pediatric Myasthenia Gravis

(MedPage Today) -- The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) or anti-muscle-specific kinase (MuSK) antibody...